Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2025

Mar 5, 2025

30786_dirs_2025-03-05_fa7baf0f-64c9-468d-84f5-406c72714d0b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIO.B)
CIK: 0000012208
Period of Report: 2025-03-03

Reporting Person: COREY COLLEEN (EVP, Global Human Resources)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-03 Non-Qualified Stock Option (right to buy) $256.45 A 1946 Acquired 2035-03-03 Bio-Rad A Common Stock (1946) Direct

Footnotes

F1: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.